Related Experiment Videos
Ivermectin, a new broad-spectrum antiparasitic agent.
Journal of Medicinal Chemistry
|October 1, 1980
Summary
Ivermectin, a derivative of avermectin B1, is a highly effective drug for treating parasitic diseases in animals. This veterinary medicine demonstrates broad efficacy against various metazoan parasites.
Area of Science:
- Veterinary Medicine
- Parasitology
- Organic Chemistry
Background:
- Metazoan parasitic diseases pose significant health challenges in animal populations.
- Avermectin B1 is a known antiparasitic agent.
Purpose of the Study:
- To evaluate the efficacy of 2,23-Dihydroavermectin B1 (ivermectin) as a treatment for metazoan parasitic diseases in animals.
Main Methods:
- Selective hydrogenation of avermectin B1 using Wilkinson's catalyst [(Ph3P)3RhCl] to synthesize 2,23-Dihydroavermectin B1.
- In vivo testing of the synthesized compound against a variety of metazoan parasites in animal models.
Main Results:
- 2,23-Dihydroavermectin B1, or ivermectin, demonstrated high efficacy in treating parasitic infections.
- The drug proved effective against a wide spectrum of metazoan parasites.
Conclusions:
- Ivermectin is a potent and effective therapeutic agent for combating metazoan parasitic diseases in veterinary medicine.
- The synthesis method using Wilkinson's catalyst provides a viable route to this important antiparasitic drug.